Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 136 B, Issue 1, 2005, Pages 87-91

  Chen, Chih Ken ^a,c   Lin, Shih Ku ^b   Sham, Pak C ^c   Ball, David ^c   Loh, El Wui ^d   Murray, Robin M ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Amphetamine; Familial risk; Genetic disposition; Psychosis; Schizophrenia; Substance abuse

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; DISEASE COURSE; DRUG ABUSE; FEMALE; GENETIC ANALYSIS; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HOSPITAL; MORBIDITY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RELATIVE; SCHIZOPHRENIA;

ADULT; AMPHETAMINE-RELATED DISORDERS; COMORBIDITY; FAMILY; FEMALE; HUMANS; INTERVIEWS; MALE; MENTAL DISORDERS; METHAMPHETAMINE; PREVALENCE; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 21444451423     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30187     Document Type: Article

References (28)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th Edn. Washinton, DC: American Psychiatric Association.
2. Andreasen NC, Rice J, Endicott J, Reich T, Coryell W. 1986. The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry 43:421-429.
3. Bell DS. 1965. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111:701-707.
4. Bowers MB, Jr. 1977. Psychoses precipitated by psychotomimetic drugs. A follow-up study. Arch Gen Psychiatry 34:832-835.
5. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, Gottesman II, Farmer AE, McGuffin P, Reveley AM, Murray RM. 1999. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry 56:162-168.
6. Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG. 1998. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry 155:1214-1220.
7. Chen CK, Lin SK, Sham P, Ball D, Loh EW, Hsiao CC, Chiang YL, Ree SC, Lee CH, Murray RM. 2003. Premorbid characteristics and comorbidity of methamphetamine users with and without psychosis. Psychol Med 33:1407-1414.
8. Chen CK, Hu X, Lin SK, Sham PC, Loh EW, Li T, Murray RM, Ball D. 2004. Association Analysis of Dopamine D2-like receptor genes and Methamphetamine Abuse. Psychiatr Genet 14:223-226.
9. Connell PH. 1958. Amphetamine Psychosis. London: Chapman and Hall Ltd.
10. Farmer AE, McGuffin P, Gottesman II. 1987. Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition. Arch Gen Psychiatry 44:634-641.
11. Flaum M, Schultz SK. 1996. When does amphetamine-induced psychosis become schizophrenia? [clinical conference]. Am J Psychiatry 153: 812-815.
12. Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI, Jr., Maxwell ME, Schreiber J, Dauphinais D, Dingman CW, Guroff JJ. 1988. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 45:328-336.
13. Gold MS, Bowers MB, Jr. 1978. Neurobiological vulnerability to low-dose amphetamine psychosis. Am J Psychiatry 135:1546-1548.
14. Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y, Horita N, Kaneko T. 1994. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand 89:428-432.
15. Kendler KS, Tsuang MT. 1988. Outcome and familial psychopathology in schizophrenia. Arch Gen Psychiatry 45:338-346.
16. Li T, Chen CK, Hu X, Ball D, Lin SK, Chen W, Sham PC, Loh EW, Murray RM, Collier DA. 2004. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet Neuropsychiatr Genet 129:120-124.
17. Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert O, Levinson DF. 1993. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry 50:871-883.
18. McDonald C, Murray RM. 2000. Early and late environmental risk factors for schizophrenia. Brain Res Rev 31:130-137.
19. McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM. 1995. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr Res 15:277-281.
20. Murray RM. 1994. Neurodevelopmental schizophrenia: The rediscovery of dementia praecox. Br J Psychiatry Suppl 25:6-12.
21. Murray RM, McDonald C, Bramon E. 2002. Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia. World Psychiatry 1:137-145.
22. Nakatani Y, Yoshizawa F, Yamada H, Iwanami A, Sakaguchi M, Katoh N. 1989. Methamphetamine psychosis in Japan: A survey [letter]. Br J Addict 84:1548-1549.
23. Nurnberger JI, Jr., Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative. Arch Gen Psychiatry 51:849-859.
24. Tatetsu S, Goto A, Fujiwara T. 1956. The Methamphetamine Psychosis. Tokyo: Igakushoin.
25. Tsuang MT, Simpson JC, Kronfol Z. 1982. Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. Arch Gen Psychiatry 39:141-147.
26. Tsuang MT, Stone WS, Faraone SV. 2001. Genes, environment and schizophrenia. Br J Psychiatry 178:18-24.
27. van Os J, Jones P, Sham P, Bebbington P, Murray RM. 1998. Risk factors for onset and persistence of psychosis. Soc Psychiatry Psychiatr Epidemiol 33:596-605.
28. Verdoux H, van Os J, Sham P, Jones P, Gilvarry K, Murray R. 1996. Does familiality predispose to both emergence and persistence of psychosis? A follow-up study. Br J Psychiatry 168:620-626.